Biotechnology
The Biotechnology industry has a total of 655 stocks, with a combined market cap of $759.6 billion and total revenue of $95.38 billion.
Market Cap
759.6B
Revenue
95.38B
Profits
-46.7B
PE Ratio
n/a
Profit Margin
-48.96%
Dividend Yield
0.05%
655 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 112.47B | -2.68% | 1,842,533 | 11.10B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 59.52B | 0.85% | 404,686 | 14.09B |
| 3 | ARGX | argenx SE | 39.26B | 1.21% | 188,956 | 2.25B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 35.99B | 2.31% | 236,508 | 2.35B |
| 5 | ONC | BeiGene, Ltd. | 25.27B | -3.14% | 287,031 | 4.18B |
| 6 | BNTX | BioNTech SE | 22.70B | -0.35% | 529,170 | 2.97B |
| 7 | RPRX | Royalty Pharma plc | 18.75B | 1.28% | 1,087,154 | 2.26B |
| 8 | SMMT | Summit Therapeutics Inc. | 17.99B | 0.08% | 1,307,942 | - |
| 9 | GMAB | Genmab A/S | 13.18B | 1.91% | 917,728 | 2.99B |
| 10 | INSM | Insmed Incorporated | 12.49B | 1.25% | 480,473 | 363.71M |
| 11 | INCY | Incyte Corporation | 11.59B | 0.40% | 419,717 | 4.41B |
| 12 | BMRN | BioMarin Pharmaceutical Inc. | 11.42B | -0.17% | 350,097 | 2.95B |
| 13 | EXEL | Exelixis, Inc. | 10.17B | 0.09% | 772,680 | 2.17B |
| 14 | ASND | Ascendis Pharma A/S | 9.90B | 0.69% | 270,017 | 398.51M |
| 15 | MRNA | Moderna, Inc. | 9.28B | -1.74% | 5,405,440 | 3.18B |
| 16 | HALO | Halozyme Therapeutics, Inc. | 8.53B | 16.54% | 5,367,831 | 1.08B |
| 17 | ROIV | Roivant Sciences Ltd. | 8.01B | 1.45% | 1,011,248 | 122.59M |
| 18 | TECH | Bio-Techne Corporation | 7.64B | 1.30% | 1,653,695 | 1.21B |
| 19 | CORT | Corcept Therapeutics Incorporated | 7.56B | 0.84% | 543,983 | 685.45M |
| 20 | RVMD | Revolution Medicines, Inc. | 7.00B | 0.53% | 694,895 | - |
| 21 | BBIO | BridgeBio Pharma, Inc. | 6.90B | -1.69% | 1,533,398 | 127.42M |
| 22 | MDGL | Madrigal Pharmaceuticals, Inc. | 6.50B | -0.79% | 94,245 | 317.38M |
| 23 | BPMC | Blueprint Medicines Corporation | 6.47B | 1.09% | 242,227 | 562.12M |
| 24 | VRNA | Verona Pharma plc | 6.36B | -0.37% | 309,567 | 118.54M |
| 25 | JAZZ | Jazz Pharmaceuticals plc | 6.18B | -8.40% | 1,422,893 | 4.06B |
| 26 | TLX | Telix Pharmaceuticals Limited | 5.94B | -1.59% | 16,288 | 484.69M |
| 27 | LEGN | Legend Biotech Corporation | 5.83B | 1.12% | 771,377 | 627.24M |
| 28 | ADMA | ADMA Biologics, Inc. | 5.68B | 3.07% | 1,381,274 | 426.45M |
| 29 | TGTX | TG Therapeutics, Inc. | 5.55B | 0.34% | 1,221,245 | 386.39M |
| 30 | AXSM | Axsome Therapeutics, Inc. | 5.48B | -0.68% | 337,433 | 432.16M |
| 31 | IONS | Ionis Pharmaceuticals, Inc. | 5.22B | 3.01% | 286,642 | 717.25M |
| 32 | NUVL | Nuvalent, Inc. | 4.87B | -0.26% | 354,672 | - |
| 33 | RYTM | Rhythm Pharmaceuticals, Inc. | 4.11B | 3.03% | 324,385 | 136.86M |
| 34 | CYTK | Cytokinetics, Incorporated | 3.99B | -1.59% | 1,668,280 | 19.22M |
| 35 | KRYS | Krystal Biotech, Inc. | 3.97B | -1.46% | 201,459 | 333.45M |
| 36 | PCVX | Vaxcyte, Inc. | 3.79B | 0.41% | 1,294,718 | - |
| 37 | SLNO | Soleno Therapeutics, Inc. | 3.76B | 2.33% | 407,104 | - |
| 38 | SRPT | Sarepta Therapeutics, Inc. | 3.70B | -19.51% | 11,558,566 | 2.23B |
| 39 | SWTX | SpringWorks Therapeutics, Inc. | 3.44B | 0.09% | 4,009,675 | 191.59M |
| 40 | AKRO | Akero Therapeutics, Inc. | 3.41B | 2.07% | 311,294 | - |
| 41 | PTCT | PTC Therapeutics, Inc. | 3.22B | 12.38% | 1,056,848 | 1.77B |
| 42 | RNA | Avidity Biosciences, Inc. | 3.19B | 0.91% | 819,567 | 10.90M |
| 43 | RARE | Ultragenyx Pharmaceutical Inc. | 3.18B | -3.28% | 701,737 | 590.69M |
| 44 | ZLAB | Zai Lab Limited | 3.15B | -2.48% | 337,083 | 398.99M |
| 45 | VKTX | Viking Therapeutics, Inc. | 3.10B | 2.15% | 1,253,595 | - |
| 46 | CRSP | CRISPR Therapeutics AG | 2.96B | 3.41% | 1,466,783 | 37.31M |
| 47 | CRNX | Crinetics Pharmaceuticals, Inc. | 2.96B | 3.57% | 171,313 | 1.04M |
| 48 | ACLX | Arcellx, Inc. | 2.88B | -1.08% | 1,115,098 | 107.94M |
| 49 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.84B | 0.95% | 326,274 | 491.73M |
| 50 | SRRK | Scholar Rock Holding Corporation | 2.81B | 1.06% | 311,742 | - |
| 51 | MRUS | Merus N.V. | 2.78B | 1.79% | 377,576 | 36.13M |
| 52 | XENE | Xenon Pharmaceuticals Inc. | 2.71B | 0.71% | 377,525 | - |
| 53 | PTGX | Protagonist Therapeutics, Inc. | 2.66B | 2.31% | 249,503 | 207.80M |
| 54 | ACAD | ACADIA Pharmaceuticals Inc. | 2.44B | 0.65% | 642,253 | 957.80M |
| 55 | MLTX | MoonLake Immunotherapeutics | 2.43B | -2.25% | 228,942 | - |
| 56 | IMVT | Immunovant, Inc. | 2.41B | 2.67% | 518,420 | - |
| 57 | MTSR | Metsera, Inc. | 2.41B | 0.88% | 540,405 | - |
| 58 | APLS | Apellis Pharmaceuticals, Inc. | 2.19B | -9.05% | 3,315,065 | 775.84M |
| 59 | NAMS | NewAmsterdam Pharma Company N.V. | 2.09B | 0.34% | 309,001 | 45.56M |
| 60 | APGE | Apogee Therapeutics, Inc. | 2.08B | 0.65% | 209,068 | - |
| 61 | MIRM | Mirum Pharmaceuticals, Inc. | 2.06B | 1.37% | 105,750 | 336.89M |
| 62 | AAPG | Ascentage Pharma Group International | 2.05B | -5.62% | 22,412 | 134.35M |
| 63 | DNLI | Denali Therapeutics Inc. | 2.03B | 0.07% | 601,528 | - |
| 64 | LGND | Ligand Pharmaceuticals Incorporated | 2.01B | 1.00% | 14,935 | 167.13M |
| 65 | BHVN | Biohaven Ltd. | 2.01B | 2.71% | 631,644 | - |
| 66 | TARS | Tarsus Pharmaceuticals, Inc. | 1.98B | 1.29% | 63,345 | 233.67M |
| 67 | VCEL | Vericel Corporation | 1.98B | 2.51% | 156,473 | 237.22M |
| 68 | BLTE | Belite Bio, Inc | 1.94B | -0.15% | 2,895 | - |
| 69 | HRMY | Harmony Biosciences Holdings, Inc. | 1.93B | 4.65% | 427,826 | 744.85M |
| 70 | KYMR | Kymera Therapeutics, Inc. | 1.91B | 3.08% | 218,597 | 47.07M |
| 71 | FOLD | Amicus Therapeutics, Inc. | 1.90B | -0.48% | 2,169,924 | 543.14M |
| 72 | TVTX | Travere Therapeutics, Inc. | 1.82B | 2.56% | 374,318 | 273.53M |
| 73 | GLPG | Galapagos NV | 1.77B | -0.99% | 306,096 | 311.49M |
| 74 | CGON | CG Oncology, Inc. | 1.74B | 5.25% | 1,581,933 | 1.14M |
| 75 | RXRX | Recursion Pharmaceuticals, Inc. | 1.73B | 2.53% | 10,416,382 | 59.79M |
| 76 | IBRX | ImmunityBio, Inc. | 1.70B | -3.98% | 11,175,679 | 14.75M |
| 77 | AGIO | Agios Pharmaceuticals, Inc. | 1.66B | 0.99% | 147,513 | 37.04M |
| 78 | ARWR | Arrowhead Pharmaceuticals, Inc. | 1.65B | 0.23% | 292,429 | 2.50M |
| 79 | CNTA | Centessa Pharmaceuticals plc | 1.62B | 1.50% | 173,326 | - |
| 80 | ARQT | Arcutis Biotherapeutics, Inc. | 1.62B | -5.17% | 3,087,339 | 212.82M |
| 81 | IDYA | IDEAYA Biosciences, Inc. | 1.59B | 2.48% | 662,771 | 7.00M |
| 82 | BEAM | Beam Therapeutics Inc. | 1.58B | 0.75% | 1,317,919 | 63.58M |
| 83 | EWTX | Edgewise Therapeutics, Inc. | 1.56B | 3.20% | 359,287 | - |
| 84 | JANX | Janux Therapeutics, Inc. | 1.51B | - | 507,679 | 10.59M |
| 85 | IMCR | Immunocore Holdings plc | 1.50B | 7.02% | 72,362 | 333.58M |
| 86 | GPCR | Structure Therapeutics Inc. | 1.49B | 2.61% | 203,868 | - |
| 87 | IRON | Disc Medicine, Inc. | 1.48B | 0.16% | 183,151 | - |
| 88 | MNKD | MannKind Corporation | 1.46B | 0.84% | 554,582 | 285.50M |
| 89 | VERA | Vera Therapeutics, Inc. | 1.43B | 1.54% | 556,200 | - |
| 90 | MESO | Mesoblast Limited | 1.43B | 0.74% | 63,488 | 5.67M |
| 91 | BTX | BlackRock Innovation and Growth Term Trust | 1.40B | 0.16% | 141,086 | - |
| 92 | LQDA | Liquidia Corporation | 1.35B | 1.71% | 208,411 | 14.00M |
| 93 | SPRY | ARS Pharmaceuticals, Inc. | 1.31B | -4.99% | 567,995 | 89.15M |
| 94 | ADPT | Adaptive Biotechnologies Corporation | 1.30B | -2.84% | 1,215,955 | 189.53M |
| 95 | CLDX | Celldex Therapeutics, Inc. | 1.26B | 3.10% | 230,978 | 7.02M |
| 96 | INVA | Innoviva, Inc. | 1.18B | 0.48% | 84,253 | 358.71M |
| 97 | OCUL | Ocular Therapeutix, Inc. | 1.16B | 1.32% | 581,999 | 59.65M |
| 98 | ETNB | 89bio, Inc. | 1.13B | -0.52% | 434,911 | - |
| 99 | AUPH | Aurinia Pharmaceuticals Inc. | 1.10B | -0.86% | 233,531 | 235.13M |
| 100 | DYN | Dyne Therapeutics, Inc. | 1.07B | -5.59% | 1,812,481 | - |
| 101 | IOVA | Iovance Biotherapeutics, Inc. | 1.03B | 1.61% | 3,836,660 | 164.07M |
| 102 | WVE | Wave Life Sciences Ltd. | 1.02B | 3.43% | 685,793 | 108.30M |
| 103 | VRDN | Viridian Therapeutics, Inc. | 991.34M | 1.00% | 276,792 | 302.00K |
| 104 | MDXG | MiMedx Group, Inc. | 988.13M | 1.21% | 130,072 | 352.38M |
| 105 | NVAX | Novavax, Inc. | 969.10M | -0.49% | 1,623,322 | 682.16M |
| 106 | OCS | Oculis Holding AG | 967.81M | -0.16% | 1,749 | 757.02K |
| 107 | MLYS | Mineralys Therapeutics, Inc. | 938.11M | - | 158,839 | - |
| 108 | ELVN | Enliven Therapeutics, Inc. | 910.99M | -5.59% | 23,282 | - |
| 109 | PHVS | Pharvaris N.V. | 907.31M | -1.07% | 20,561 | - |
| 110 | ARDX | Ardelyx, Inc. | 904.38M | -4.30% | 2,305,255 | 361.71M |
| 111 | SNDX | Syndax Pharmaceuticals, Inc. | 892.31M | -2.54% | 1,661,846 | 43.72M |
| 112 | GERN | Geron Corporation | 866.20M | 3.03% | 11,255,380 | 116.29M |
| 113 | GYRE | Gyre Therapeutics, Inc. | 836.18M | 2.41% | 28,369 | 105.76M |
| 114 | RCUS | Arcus Biosciences, Inc. | 825.90M | -3.94% | 947,648 | 141.00M |
| 115 | ZYME | Zymeworks Inc. | 798.74M | -2.21% | 131,619 | 76.30M |
| 116 | VIR | Vir Biotechnology, Inc. | 787.65M | 1.33% | 365,846 | 74.21M |
| 117 | SYRE | Spyre Therapeutics, Inc. | 773.94M | 2.64% | 112,023 | - |
| 118 | CRMD | CorMedix Inc. | 770.49M | 1.79% | 4,555,786 | 82.55M |
| 119 | NTLA | Intellia Therapeutics, Inc. | 762.41M | 1.59% | 1,413,312 | 57.88M |
| 120 | CVAC | CureVac N.V. | 761.03M | 0.60% | 176,283 | 554.07M |
| 121 | PRAX | Praxis Precision Medicines, Inc. | 758.95M | 5.94% | 210,614 | 8.12M |
| 122 | NRIX | Nurix Therapeutics, Inc. | 734.15M | -0.16% | 217,517 | 56.42M |
| 123 | LENZ | LENZ Therapeutics, Inc. | 723.42M | 1.45% | 33,002 | - |
| 124 | AVXL | Anavex Life Sciences Corp. | 719.68M | 2.43% | 380,553 | - |
| 125 | RCKT | Rocket Pharmaceuticals, Inc. | 716.02M | 6.42% | 1,941,937 | - |
| 126 | XERS | Xeris Biopharma Holdings, Inc. | 709.99M | 5.58% | 1,108,556 | 203.07M |
| 127 | NUVB | Nuvation Bio Inc. | 708.21M | -0.24% | 1,677,462 | 7.87M |
| 128 | AVBP | ArriVent BioPharma, Inc. | 690.87M | 3.15% | 20,813 | - |
| 129 | DAWN | Day One Biopharmaceuticals, Inc. | 675.02M | -4.72% | 1,995,935 | 161.92M |
| 130 | NAGE | Niagen Bioscience, Inc. | 668.68M | -2.63% | 679,930 | 99.60M |
| 131 | IMNM | Immunome, Inc. | 664.77M | 0.20% | 279,152 | 9.04M |
| 132 | BCAX | Bicara Therapeutics Inc. | 660.16M | -4.46% | 164,630 | - |
| 133 | SVRA | Savara Inc. | 651.77M | 3.17% | 409,883 | - |
| 134 | TRVI | Trevi Therapeutics, Inc. | 649.70M | 2.13% | 246,559 | - |
| 135 | DNTH | Dianthus Therapeutics, Inc. | 639.63M | -0.20% | 42,381 | 6.24M |
| 136 | ABUS | Arbutus Biopharma Corporation | 637.63M | 0.30% | 239,279 | 6.17M |
| 137 | GHRS | GH Research PLC | 629.59M | 0.50% | 19,152 | - |
| 138 | KALV | KalVista Pharmaceuticals, Inc. | 617.97M | -0.48% | 68,046 | - |
| 139 | PHAR | Pharming Group N.V. | 604.61M | -3.81% | 1,444 | 297.20M |
| 140 | ABCL | AbCellera Biologics Inc. | 600.45M | -0.74% | 1,023,173 | 28.83M |
| 141 | QURE | uniQure N.V. | 595.45M | -5.23% | 2,518,126 | 27.12M |
| 142 | ANAB | AnaptysBio, Inc. | 591.14M | - | 163,286 | 111.87M |
| 143 | XNCR | Xencor, Inc. | 578.46M | -3.90% | 441,450 | 110.49M |
| 144 | REPL | Replimune Group, Inc. | 566.83M | -1.87% | 720,990 | - |
| 145 | SION | Sionna Therapeutics, Inc. | 560.82M | -0.39% | 145,875 | - |
| 146 | KROS | Keros Therapeutics, Inc. | 551.96M | -1.24% | 419,106 | 214.71M |
| 147 | BCYC | Bicycle Therapeutics plc | 550.85M | 7.57% | 410,379 | 25.72M |
| 148 | VALN | Valneva SE | 547.80M | -3.21% | 4,992 | 201.10M |
| 149 | RGLS | Regulus Therapeutics Inc. | 543.15M | 0.26% | 303,647 | - |
| 150 | COGT | Cogent Biosciences, Inc. | 542.32M | 1.28% | 309,948 | - |
| 151 | MRVI | Maravai LifeSciences Holdings, Inc. | 528.38M | 1.97% | 277,510 | 259.19M |
| 152 | RLAY | Relay Therapeutics, Inc. | 516.05M | -4.44% | 1,204,024 | 7.68M |
| 153 | IMTX | Immatics N.V. | 515.37M | -7.63% | 377,812 | 161.34M |
| 154 | TBPH | Theravance Biopharma, Inc. | 512.01M | 1.49% | 64,214 | 64.38M |
| 155 | FTRE | Fortrea Holdings Inc. | 511.55M | 2.54% | 539,411 | 2.70B |
| 156 | TYRA | Tyra Biosciences, Inc. | 505.68M | -4.75% | 286,454 | - |
| 157 | ARVN | Arvinas, Inc. | 493.42M | -2.73% | 910,860 | 426.90M |
| 158 | MNMD | Mind Medicine (MindMed) Inc. | 491.84M | 3.17% | 241,145 | - |
| 159 | KURA | Kura Oncology, Inc. | 490.88M | -2.07% | 397,741 | 67.99M |
| 160 | STOK | Stoke Therapeutics, Inc. | 483.73M | 1.26% | 197,886 | 36.56M |
| 161 | UPB | Upstream Bio, Inc. | 470.69M | 6.58% | 39,660 | 2.30M |
| 162 | OPT | Opthea Limited | 466.57M | 1.49% | 3,025 | 208.86K |
| 163 | CGEM | Cullinan Therapeutics, Inc. | 463.27M | - | 106,347 | - |
| 164 | URGN | UroGen Pharma Ltd. | 463.25M | 3.72% | 361,892 | 90.40M |
| 165 | ABVX | ABIVAX Société Anonyme | 451.16M | -0.37% | 38,021 | 11.17M |
| 166 | MGTX | MeiraGTx Holdings plc | 439.22M | -5.11% | 291,723 | 33.28M |
| 167 | AMLX | Amylyx Pharmaceuticals, Inc. | 437.70M | 6.24% | 1,135,162 | 87.37M |
| 168 | SAGE | Sage Therapeutics, Inc. | 430.83M | 0.29% | 186,188 | 47.40M |
| 169 | EYPT | EyePoint Pharmaceuticals, Inc. | 427.49M | -0.48% | 433,963 | 56.04M |
| 170 | PRTC | PureTech Health plc | 416.82M | 0.06% | 172 | 4.83M |
| 171 | MAZE | Maze Therapeutics, Inc. | 406.43M | 1.87% | 41,221 | 167.50M |
| 172 | ALT | Altimmune, Inc. | 405.86M | 4.77% | 955,516 | 20.00K |
| 173 | ZVRA | Zevra Therapeutics, Inc. | 404.08M | -0.14% | 89,453 | 23.61M |
| 174 | PGEN | Precigen, Inc. | 399.90M | -2.51% | 391,413 | 3.93M |
| 175 | VERV | Verve Therapeutics, Inc. | 393.12M | 1.15% | 974,431 | 32.33M |
| 176 | TSHA | Taysha Gene Therapies, Inc. | 390.63M | -4.75% | 1,330,156 | 8.33M |
| 177 | PRTA | Prothena Corporation plc | 387.02M | -2.18% | 828,794 | 135.16M |
| 178 | SANA | Sana Biotechnology, Inc. | 386.69M | 0.29% | 641,881 | - |
| 179 | CELC | Celcuity Inc. | 385.58M | 0.69% | 78,063 | - |
| 180 | MREO | Mereo BioPharma Group plc | 382.40M | 3.22% | 772,209 | 1.00M |
| 181 | RAPP | Rapport Therapeutics, Inc. | 381.03M | 0.48% | 14,664 | - |
| 182 | ZBIO | Zenas BioPharma, Inc. | 375.78M | -0.39% | 41,100 | 5.00M |
| 183 | OMER | Omeros Corporation | 375.67M | 2.05% | 125,260 | - |
| 184 | TRML | Tourmaline Bio, Inc. | 373.00M | -0.14% | 52,775 | - |
| 185 | DNA | Ginkgo Bioworks Holdings, Inc. | 371.32M | 5.89% | 768,067 | 237.42M |
| 186 | MBX | MBX Biosciences, Inc. | 370.51M | 2.45% | 34,827 | - |
| 187 | RGNX | REGENXBIO Inc. | 361.34M | -8.96% | 727,752 | 83.33M |
| 188 | ERAS | Erasca, Inc. | 355.50M | 0.40% | 358,399 | - |
| 189 | TECX | Tectonic Therapeutic, Inc. | 353.28M | 0.05% | 40,803 | - |
| 190 | HRTX | Heron Therapeutics, Inc. | 350.82M | -4.96% | 1,111,498 | 148.52M |
| 191 | ORKA | Oruka Therapeutics, Inc. | 348.57M | 0.22% | 37,218 | - |
| 192 | CKPT | Checkpoint Therapeutics, Inc. | 348.04M | 0.12% | 577,173 | 41.00K |
| 193 | IVA | Inventiva S.A. | 347.93M | 5.22% | 3,556 | 14.59M |
| 194 | BNTC | Benitec Biopharma Inc. | 347.23M | -2.01% | 11,379 | - |
| 195 | RIGL | Rigel Pharmaceuticals, Inc. | 346.80M | 6.30% | 481,865 | 203.08M |
| 196 | ORIC | ORIC Pharmaceuticals, Inc. | 343.36M | -4.17% | 265,598 | - |
| 197 | ABSI | Absci Corporation | 338.76M | 0.38% | 959,176 | 4.53M |
| 198 | VSTM | Verastem, Inc. | 334.68M | -0.46% | 286,091 | 10.00M |
| 199 | CAPR | Capricor Therapeutics, Inc. | 333.21M | -0.07% | 3,121,734 | 22.27M |
| 200 | AUTL | Autolus Therapeutics plc | 316.69M | 0.85% | 920,852 | 10.12M |
| 201 | OLMA | Olema Pharmaceuticals, Inc. | 315.70M | 0.43% | 235,933 | - |
| 202 | SEPN | Septerna, Inc. | 310.21M | 8.22% | 51,805 | 1.08M |
| 203 | ARCT | Arcturus Therapeutics Holdings Inc. | 305.10M | 0.09% | 148,324 | 152.31M |
| 204 | IMMP | Immutep Limited | 293.69M | -4.93% | 365,572 | 3.02M |
| 205 | TRDA | Entrada Therapeutics, Inc. | 291.48M | -2.76% | 38,669 | 210.78M |
| 206 | NNNN | Anbio Biotechnology | 285.29M | -1.07% | 5,566 | 8.19M |
| 207 | ATYR | aTyr Pharma, Inc. | 285.24M | -0.62% | 649,506 | 235.00K |
| 208 | XOMA | XOMA Royalty Corporation | 279.04M | 1.32% | 6,289 | 28.49M |
| 209 | ATAI | Atai Life Sciences N.V. | 276.72M | 0.36% | 591,948 | 308.00K |
| 210 | TERN | Terns Pharmaceuticals, Inc. | 270.19M | 2.82% | 172,322 | - |
| 211 | FULC | Fulcrum Therapeutics, Inc. | 269.36M | -6.73% | 410,695 | 80.00M |
| 212 | ALLO | Allogene Therapeutics, Inc. | 268.32M | -3.52% | 1,957,825 | 22.00K |
| 213 | RNAC | Cartesian Therapeutics, Inc. | 266.84M | -2.55% | 11,992 | 38.91M |
| 214 | DBVT | DBV Technologies S.A. | 266.79M | 1.17% | 33,881 | 3.50M |
| 215 | TSVT | 2seventy bio, Inc. | 265.88M | 0.10% | 79,414 | 37.86M |
| 216 | AURA | Aura Biosciences, Inc. | 264.16M | -3.93% | 55,191 | - |
| 217 | ABEO | Abeona Therapeutics Inc. | 263.05M | -5.82% | 644,816 | - |
| 218 | VNDA | Vanda Pharmaceuticals Inc. | 259.31M | 0.69% | 136,836 | 198.77M |
| 219 | ALMS | Alumis Inc. | 257.89M | 8.97% | 630,840 | - |
| 220 | PVLA | Palvella Therapeutics, Inc. | 252.66M | -3.90% | 66,061 | - |
| 221 | SLRN | Acelyrin, Inc. | 247.75M | 1.65% | 231,712 | - |
| 222 | TVRD | Tvardi Therapeutics, Inc. | 247.45M | 0.76% | 12,240 | - |
| 223 | GLUE | Monte Rosa Therapeutics, Inc. | 247.27M | -2.78% | 67,087 | 75.62M |
| 224 | GOSS | Gossamer Bio, Inc. | 245.40M | -0.92% | 244,719 | 114.70M |
| 225 | ATXS | Astria Therapeutics, Inc. | 243.80M | -1.14% | 83,105 | - |
| 226 | LXRX | Lexicon Pharmaceuticals, Inc. | 242.75M | 1.91% | 1,486,651 | 31.08M |
| 227 | CMPX | Compass Therapeutics, Inc. | 242.69M | 3.85% | 1,203,478 | 850.00K |
| 228 | AVIR | Atea Pharmaceuticals, Inc. | 240.75M | 0.54% | 146,965 | - |
| 229 | ITOS | iTeos Therapeutics, Inc. | 240.74M | -4.98% | 110,241 | 35.00M |
| 230 | GNFT | Genfit S.A. | 232.78M | -4.11% | - | 73.19M |
| 231 | CELZ | Creative Medical Technology Holdings, Inc. | 232.33M | - | 6,067 | 11.00K |
| 232 | THRD | Third Harmonic Bio, Inc. | 232.31M | - | 109,216 | - |
| 233 | MNPR | Monopar Therapeutics Inc. | 230.57M | -2.73% | 4,493 | - |
| 234 | AARD | Aardvark Therapeutics, Inc. | 229.98M | 1.63% | 3,367 | - |
| 235 | RZLT | Rezolute, Inc. | 225.80M | -0.80% | 358,041 | - |
| 236 | SLDB | Solid Biosciences Inc. | 225.53M | -13.65% | 900,754 | - |
| 237 | FHTX | Foghorn Therapeutics Inc. | 222.45M | 0.50% | 80,804 | 22.60M |
| 238 | CRVS | Corvus Pharmaceuticals, Inc. | 222.12M | -2.69% | 405,479 | - |
| 239 | PLX | Protalix BioTherapeutics, Inc. | 218.49M | 2.56% | 211,349 | 53.40M |
| 240 | CDTX | Cidara Therapeutics, Inc. | 215.29M | -0.20% | - | 1.28M |
| 241 | CADL | Candel Therapeutics, Inc. | 212.56M | -1.96% | 340,220 | - |
| 242 | DRUG | Bright Minds Biosciences Inc. | 209.63M | 5.10% | 20,021 | - |
| 243 | TENX | Tenax Therapeutics, Inc. | 204.36M | 6.34% | 3,841 | - |
| 244 | KOD | Kodiak Sciences Inc. | 202.67M | 1.32% | 137,320 | - |
| 245 | IPHA | Innate Pharma S.A. | 201.21M | 3.11% | 96,498 | 20.83M |
| 246 | NVCT | Nuvectis Pharma, Inc. | 199.76M | -4.69% | 93,091 | - |
| 247 | OCGN | Ocugen, Inc. | 199.65M | -4.40% | 1,084,911 | 4.06M |
| 248 | PROK | ProKidney Corp. | 197.92M | -2.00% | 123,429 | 76.00K |
| 249 | DSGN | Design Therapeutics, Inc. | 194.15M | -5.79% | 22,350 | - |
| 250 | DRTS | Alpha Tau Medical Ltd. | 192.14M | 5.41% | 27,602 | - |
| 251 | HUMA | Humacyte, Inc. | 190.80M | - | 623,384 | - |
| 252 | MDWD | MediWound Ltd. | 190.22M | -1.07% | 10,812 | 20.22M |
| 253 | CDXS | Codexis, Inc. | 189.71M | 1.55% | 93,389 | 59.35M |
| 254 | NGNE | Neurogene Inc. | 188.69M | 1.38% | 39,842 | 925.00K |
| 255 | ENGNW | enGene Holdings Inc. | 188.11M | -14.19% | 11,331 | - |
| 256 | TVGN | Tevogen Bio Holdings Inc. | 187.57M | -2.86% | 258,090 | - |
| 257 | CRGX | CARGO Therapeutics, Inc. | 186.97M | -0.49% | 80,000 | - |
| 258 | ANNX | Annexon, Inc. | 186.51M | 3.34% | 220,469 | - |
| 259 | ENGN | enGene Holdings Inc. | 186.07M | -1.08% | 10,234 | - |
| 260 | SLN | Silence Therapeutics plc | 184.65M | 4.27% | 113,340 | 43.26M |
| 261 | OABI | OmniAb, Inc. | 184.42M | -2.58% | 123,670 | 26.39M |
| 262 | VYGR | Voyager Therapeutics, Inc. | 183.09M | 1.85% | 131,144 | 66.96M |
| 263 | TLSA | Tiziana Life Sciences Ltd | 181.08M | 10.67% | 737,149 | - |
| 264 | YMAB | Y-mAbs Therapeutics, Inc. | 177.26M | 1.55% | 63,848 | 87.69M |
| 265 | ACTU | Actuate Therapeutics, Inc. | 176.57M | -1.85% | 9,858 | - |
| 266 | PRME | Prime Medicine, Inc. | 176.18M | 3.76% | 578,570 | 2.98M |
| 267 | ELDN | Eledon Pharmaceuticals, Inc. | 172.76M | 0.52% | 65,772 | - |
| 268 | INBX | Inhibrx Biosciences, Inc. | 172.26M | -4.34% | 11,823 | 200.00K |
| 269 | PHAT | Phathom Pharmaceuticals, Inc. | 169.94M | 1.67% | 1,196,310 | 81.86M |
| 270 | HURA | TuHURA Biosciences, Inc. | 166.20M | 2.01% | 38,749 | - |
| 271 | FENC | Fennec Pharmaceuticals Inc. | 165.84M | -4.30% | 37,941 | 47.54M |
| 272 | PRQR | ProQR Therapeutics N.V. | 165.71M | 0.96% | 176,518 | 20.24M |
| 273 | DMAC | DiaMedica Therapeutics Inc. | 165.42M | -3.50% | 61,262 | - |
| 274 | INMB | INmune Bio, Inc. | 165.03M | 0.70% | 49,370 | 14.00K |
| 275 | CRDF | Cardiff Oncology, Inc. | 164.32M | -3.14% | 393,507 | 683.00K |
| 276 | NBTX | Nanobiotix S.A. | 162.19M | 0.53% | - | -7.44M |
| 277 | ACIU | AC Immune SA | 159.30M | -0.62% | 42,399 | 32.01M |
| 278 | SLS | SELLAS Life Sciences Group, Inc. | 155.35M | -0.58% | 778,832 | - |
| 279 | MOLN | Molecular Partners AG | 155.04M | -3.92% | - | 5.48M |
| 280 | FDMT | 4D Molecular Therapeutics, Inc. | 145.85M | 2.27% | 94,534 | 37.00K |
| 281 | PBYI | Puma Biotechnology, Inc. | 145.42M | -1.68% | 165,275 | 230.47M |
| 282 | EPRX | Eupraxia Pharmaceuticals Inc. | 144.16M | 1.25% | 5,207 | - |
| 283 | CUPR | Cuprina Holdings (Cayman) Limited | 139.44M | 14.98% | 66,992 | 71.62K |
| 284 | LRMR | Larimar Therapeutics, Inc. | 138.62M | 3.10% | 892,481 | - |
| 285 | KRRO | Korro Bio, Inc. | 138.02M | -0.64% | 14,227 | 2.27M |
| 286 | ACRS | Aclaris Therapeutics, Inc. | 135.35M | -2.34% | 145,293 | 18.72M |
| 287 | SGMO | Sangamo Therapeutics, Inc. | 135.28M | -1.63% | 4,694,305 | 57.80M |
| 288 | NKTX | Nkarta, Inc. | 134.46M | 1.88% | 85,571 | - |
| 289 | IKT | Inhibikase Therapeutics, Inc. | 133.81M | -7.22% | 63,808 | 1.00 |
| 290 | CYBN | Cybin Inc. | 130.63M | 2.14% | 61,873 | - |
| 291 | TNGX | Tango Therapeutics, Inc. | 129.73M | -4.76% | 125,911 | 42.07M |
| 292 | ADCT | ADC Therapeutics SA | 128.44M | 0.39% | 18,582 | 70.84M |
| 293 | THTX | Theratechnologies Inc. | 126.16M | -1.09% | 42,749 | 88.67M |
| 294 | TNXP | Tonix Pharmaceuticals Holding Corp. | 125.13M | 2.99% | 119,327 | 10.09M |
| 295 | GLSI | Greenwich LifeSciences, Inc. | 124.51M | -4.87% | 48,140 | - |
| 296 | TARA | Protara Therapeutics, Inc. | 124.27M | 0.30% | 131,702 | - |
| 297 | CLLS | Cellectis S.A. | 123.05M | -1.90% | 8,760 | 49.22M |
| 298 | ACOG | Alpha Cognition Inc. | 121.75M | 9.20% | 169,629 | - |
| 299 | ALDX | Aldeyra Therapeutics, Inc. | 120.09M | -4.52% | 758,986 | - |
| 300 | SCPH | scPharmaceuticals Inc. | 119.17M | 3.49% | 83,069 | 36.33M |
| 301 | LYEL | Lyell Immunopharma, Inc. | 118.87M | -3.18% | 132,071 | 61.00K |
| 302 | CGEN | Compugen Ltd. | 118.76M | 0.79% | 84,177 | 27.86M |
| 303 | EDIT | Editas Medicine, Inc. | 115.10M | 3.38% | 574,551 | 32.31M |
| 304 | NKTR | Nektar Therapeutics | 114.79M | -3.93% | 1,475,756 | 98.43M |
| 305 | CCCC | C4 Therapeutics, Inc. | 114.29M | 14.18% | 1,620,233 | 39.78M |
| 306 | FATE | Fate Therapeutics, Inc. | 113.09M | 3.03% | 745,753 | 13.63M |
| 307 | VIGL | Vigil Neuroscience, Inc. | 111.54M | -0.83% | 68,757 | - |
| 308 | SEER | Seer, Inc. | 111.49M | -1.32% | 69,908 | 14.17M |
| 309 | COYA | Coya Therapeutics, Inc. | 109.38M | 12.56% | 66,867 | 3.55M |
| 310 | SGMT | Sagimet Biosciences Inc. | 108.50M | 3.06% | 55,676 | - |
| 311 | ENTA | Enanta Pharmaceuticals, Inc. | 107.73M | - | 21,530 | 66.59M |
| 312 | CHRS | Coherus BioSciences, Inc. | 107.23M | -0.53% | 346,247 | 266.96M |
| 313 | LXEO | Lexeo Therapeutics, Inc. | 106.23M | -1.54% | 992,014 | - |
| 314 | IFRX | InflaRx N.V. | 105.46M | -3.11% | 45,812 | 171.64K |
| 315 | NMRA | Neumora Therapeutics, Inc. | 105.35M | -3.20% | 223,549 | - |
| 316 | ATOS | Atossa Therapeutics, Inc. | 105.31M | -1.91% | 270,269 | - |
| 317 | ALEC | Alector, Inc. | 101.99M | -2.86% | 320,629 | 100.56M |
| 318 | RAPT | RAPT Therapeutics, Inc. | 101.75M | -5.07% | 239,978 | - |
| 319 | CTNM | Contineum Therapeutics, Inc. | 99.86M | 1.05% | 9,453 | - |
| 320 | IMUX | Immunic, Inc. | 99.65M | -2.80% | 349,558 | - |
| 321 | GALT | Galectin Therapeutics Inc. | 98.25M | 14.34% | 137,594 | - |
| 322 | ASMB | Assembly Biosciences, Inc. | 97.54M | 2.85% | 13,357 | 28.52M |
| 323 | LCTX | Lineage Cell Therapeutics, Inc. | 97.07M | -2.28% | 245,113 | 9.50M |
| 324 | ENTX | Entera Bio Ltd. | 96.29M | -2.30% | 14,719 | 181.00K |
| 325 | NTHI | NeOnc Technologies Holdings, Inc. | 95.79M | 10.85% | 55,424 | 83.00K |
| 326 | MGNX | MacroGenics, Inc. | 94.00M | 1.36% | 184,346 | 149.96M |
| 327 | OBIO | Orchestra BioMed Holdings, Inc. | 93.29M | 0.62% | 105,273 | 2.64M |
| 328 | ORMP | Oramed Pharmaceuticals Inc. | 91.51M | 0.45% | 2,743 | - |
| 329 | PLRX | Pliant Therapeutics, Inc. | 91.47M | 4.20% | 261,010 | - |
| 330 | INZY | Inozyme Pharma, Inc. | 91.22M | 12.70% | 1,731,074 | - |
| 331 | HLVX | HilleVax, Inc. | 91.06M | -1.60% | 92,235 | - |
| 332 | EXOZ | eXoZymes, Inc. | 90.00M | -0.88% | 3,107 | -700.00 |
| 333 | VXRT | Vaxart, Inc. | 88.92M | 3.01% | 399,505 | 28.70M |
| 334 | ZNTL | Zentalis Pharmaceuticals, Inc. | 88.33M | -1.60% | 365,582 | 67.43M |
| 335 | KLRS | Kalaris Therapeutics, Inc. | 88.28M | -1.46% | 7,038 | - |
| 336 | VTYX | Ventyx Biosciences, Inc. | 88.24M | 2.48% | 160,261 | - |
| 337 | BDTX | Black Diamond Therapeutics, Inc. | 87.85M | 5.80% | 217,856 | - |
| 338 | KYTX | Kyverna Therapeutics, Inc. | 87.30M | 0.50% | 95,329 | - |
| 339 | NAUT | Nautilus Biotechnology, Inc. | 86.85M | 3.08% | 26,596 | - |
| 340 | ANIX | Anixa Biosciences, Inc. | 85.80M | 1.33% | 5,287 | - |
| 341 | ACHV | Achieve Life Sciences, Inc. | 85.67M | -0.20% | 39,740 | - |
| 342 | GNLX | Genelux Corporation | 85.41M | -1.72% | 28,570 | 8.00K |
| 343 | XBIT | XBiotech Inc. | 85.06M | 0.36% | 8,195 | - |
| 344 | SNTI | Senti Biosciences, Inc. | 85.03M | -0.91% | 7,970 | - |
| 345 | MIST | Milestone Pharmaceuticals Inc. | 84.49M | -0.39% | 287,638 | - |
| 346 | ELTX | Elicio Therapeutics, Inc. | 82.88M | 1.36% | 13,994 | - |
| 347 | ZURA | Zura Bio Limited | 80.68M | -3.28% | 228,291 | - |
| 348 | CSBR | Champions Oncology, Inc. | 80.46M | 0.51% | 20,156 | 58.59M |
| 349 | CLYM | Climb Bio, Inc. | 80.42M | -0.83% | 12,309 | - |
| 350 | TIL | Instil Bio, Inc. | 80.40M | -2.99% | 24,516 | - |
| 351 | STRO | Sutro Biopharma, Inc. | 79.66M | -0.61% | 195,100 | 62.04M |
| 352 | TCRX | TScan Therapeutics, Inc. | 79.23M | 2.94% | 36,701 | 4.42M |
| 353 | AGEN | Agenus Inc. | 79.21M | -1.85% | 127,402 | 103.46M |
| 354 | ADAP | Adaptimmune Therapeutics plc | 78.52M | -0.83% | 231,651 | 178.03M |
| 355 | SRZN | Surrozen, Inc. | 78.15M | -6.69% | - | 10.66M |
| 356 | EPIX | ESSA Pharma Inc. | 77.24M | 1.16% | 11,030 | - |
| 357 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 77.19M | 0.96% | 50,697 | - |
| 358 | CTMX | CytomX Therapeutics, Inc. | 76.62M | -1.01% | 1,186,545 | 138.10M |
| 359 | MCRB | Seres Therapeutics, Inc. | 75.76M | 1.64% | 20,368 | - |
| 360 | CRVO | CervoMed Inc. | 75.71M | -7.25% | 297,032 | 9.74M |
| 361 | IVVD | Invivyd, Inc. | 75.12M | 18.46% | 10,427,903 | 25.38M |
| 362 | BYSI | BeyondSpring Inc. | 74.99M | -12.68% | 88,453 | 1.88M |
| 363 | ADAG | Adagene Inc. | 74.90M | -1.85% | 18,335 | 103.20K |
| 364 | SAVA | Cassava Sciences, Inc. | 74.88M | 2.65% | 233,242 | - |
| 365 | TELO | Telomir Pharmaceuticals, Inc. | 74.70M | - | 43,281 | - |
| 366 | GNTA | Genenta Science S.p.A. | 74.60M | -4.03% | 899 | - |
| 367 | GUTS | Fractyl Health, Inc. | 73.95M | 0.67% | 91,809 | 93.00K |
| 368 | UNCY | Unicycive Therapeutics, Inc. | 73.63M | 1.59% | 286,984 | - |
| 369 | VERU | Veru Inc. | 73.53M | 0.04% | 166,882 | 16.89M |
| 370 | WHWK | Whitehawk Therapeutics, Inc. | 73.45M | -0.63% | 4,982 | 25.98M |
| 371 | MNOV | MediciNova, Inc. | 72.59M | -1.33% | 4,242 | - |
| 372 | TNYA | Tenaya Therapeutics, Inc. | 72.27M | -4.78% | 1,588,417 | - |
| 373 | IMAB | I-Mab | 71.97M | -0.91% | 23,018 | 569.46K |
| 374 | CNTX | Context Therapeutics Inc. | 70.96M | -2.06% | 7,332 | - |
| 375 | CBUS | Cibus, Inc. | 70.76M | -0.48% | 6,711 | 4.26M |
| 376 | ANL | Adlai Nortye Ltd. | 70.48M | -2.06% | 2,859 | 1.94M |
| 377 | CYCC | Cyclacel Pharmaceuticals, Inc. | 69.52M | -5.28% | 1,484,159 | 43.00K |
| 378 | CRBU | Caribou Biosciences, Inc. | 68.84M | -1.87% | 120,623 | 9.99M |
| 379 | ADVM | Adverum Biotechnologies, Inc. | 68.31M | 1.24% | 68,034 | 1.00M |
| 380 | IGMS | IGM Biosciences, Inc. | 68.14M | -2.56% | 44,320 | 2.68M |
| 381 | JSPR | Jasper Therapeutics, Inc. | 68.05M | -4.43% | 101,618 | - |
| 382 | VOR | Vor Biopharma Inc. | 67.43M | -4.37% | 178,151 | - |
| 383 | PYXS | Pyxis Oncology, Inc. | 66.52M | 0.93% | 103,429 | 16.15M |
| 384 | VTVT | vTv Therapeutics Inc. | 66.41M | -3.97% | 1,624 | 1.02M |
| 385 | CLSD | Clearside Biomedical, Inc. | 65.69M | -1.16% | 28,768 | 1.66M |
| 386 | XCUR | Exicure, Inc. | 64.76M | -2.38% | 6,701 | 500.00K |
| 387 | NTRB | Nutriband Inc. | 64.62M | -3.49% | 19,420 | 2.14M |
| 388 | IOBT | IO Biotech, Inc. | 64.56M | -8.41% | 54,910 | - |
| 389 | INO | Inovio Pharmaceuticals, Inc. | 63.81M | 1.75% | 160,693 | 217.76K |
| 390 | BMEA | Biomea Fusion, Inc. | 63.12M | 0.60% | 224,107 | - |
| 391 | VANI | Vivani Medical, Inc. | 61.04M | 0.03% | 10,842 | - |
| 392 | VTGN | Vistagen Therapeutics, Inc. | 60.90M | -1.86% | 28,217 | 698.00K |
| 393 | RPTX | Repare Therapeutics Inc. | 59.94M | 6.02% | 142,826 | 53.48M |
| 394 | MAIA | MAIA Biotechnology, Inc. | 59.62M | -2.18% | 132,231 | - |
| 395 | CABA | Cabaletta Bio, Inc. | 59.12M | 1.30% | 141,835 | - |
| 396 | ANRO | Alto Neuroscience, Inc. | 59.02M | -0.46% | 278,376 | - |
| 397 | ABOS | Acumen Pharmaceuticals, Inc. | 58.47M | -3.48% | 37,913 | - |
| 398 | IMMX | Immix Biopharma, Inc. | 58.22M | 7.69% | 11,685 | - |
| 399 | SER | Serina Therapeutics, Inc. | 57.61M | 0.17% | 1,033 | 56.00K |
| 400 | CUE | Cue Biopharma, Inc. | 57.45M | 1.63% | 65,844 | 9.29M |
| 401 | APLT | Applied Therapeutics, Inc. | 57.35M | -0.44% | 405,419 | 455.00K |
| 402 | SKYE | Skye Bioscience, Inc. | 57.30M | -0.27% | 69,069 | - |
| 403 | RENB | Renovaro Inc. | 56.68M | 12.44% | 420,770 | - |
| 404 | DTIL | Precision BioSciences, Inc. | 55.03M | 2.94% | 17,819 | 68.70M |
| 405 | RANI | Rani Therapeutics Holdings, Inc. | 54.84M | -11.67% | 301,734 | 1.03M |
| 406 | MGX | Metagenomi, Inc. | 54.58M | 1.04% | 136,024 | 52.30M |
| 407 | GANX | Gain Therapeutics, Inc. | 54.18M | 3.17% | 108,016 | - |
| 408 | PDSB | PDS Biotechnology Corporation | 53.57M | -0.84% | 36,615 | - |
| 409 | IKNA | Ikena Oncology, Inc. | 53.33M | -1.34% | 84,134 | - |
| 410 | ATHE | Alterity Therapeutics Limited | 53.29M | -3.61% | 37,216 | 2.30M |
| 411 | KPTI | Karyopharm Therapeutics Inc. | 53.14M | -1.12% | 20,085 | 145.24M |
| 412 | FBIO | Fortress Biotech, Inc. | 52.27M | 1.72% | 75,148 | 57.68M |
| 413 | ARMP | Armata Pharmaceuticals, Inc. | 49.93M | -9.80% | 5,680 | 5.17M |
| 414 | JBIO | Jade Biosciences, Inc. | 49.90M | -1.09% | 100,072 | - |
| 415 | OKYO | OKYO Pharma Limited | 49.38M | -2.34% | 5,083 | - |
| 416 | ARTV | Artiva Biotherapeutics, Inc. | 49.21M | 5.21% | 57,259 | 251.00K |
| 417 | AVTX | Avalo Therapeutics, Inc. | 48.66M | -4.60% | 14,173 | 441.00K |
| 418 | OTLK | Outlook Therapeutics, Inc. | 46.81M | 0.35% | 111,060 | - |
| 419 | PMVP | PMV Pharmaceuticals, Inc. | 46.65M | 3.25% | 175,420 | - |
| 420 | ICCC | ImmuCell Corporation | 46.26M | 1.58% | 2,374 | 26.49M |
| 421 | QNCX | Quince Therapeutics, Inc. | 45.76M | -0.95% | 265,563 | - |
| 422 | CNTB | Connect Biopharma Holdings Limited | 45.39M | 3.54% | 44,444 | 26.03M |
| 423 | ANEB | Anebulo Pharmaceuticals, Inc. | 45.19M | -0.90% | 42,252 | - |
| 424 | PRLD | Prelude Therapeutics Incorporated | 45.09M | 0.33% | 25,860 | 7.00M |
| 425 | ATRA | Atara Biotherapeutics, Inc. | 44.94M | 5.79% | 138,110 | 128.94M |
| 426 | OSTX | OS Therapies Incorporated | 44.84M | -11.54% | 1,217,030 | - |
| 427 | IPSC | Century Therapeutics, Inc. | 44.76M | -1.98% | 73,546 | 6.59M |
| 428 | CAMP | Camp4 Therapeutics Corporation | 44.68M | -4.40% | 328,771 | 652.00K |
| 429 | ACET | Adicet Bio, Inc. | 44.65M | -10.42% | 243,430 | - |
| 430 | KRON | Kronos Bio, Inc. | 44.60M | 3.00% | 5,502 | 9.85M |
| 431 | LTRN | Lantern Pharma Inc. | 44.22M | 7.61% | 41,891 | - |
| 432 | ONCY | Oncolytics Biotech Inc. | 44.00M | 0.59% | 88,346 | - |
| 433 | LIMN | Liminatus Pharma, LLC | 43.86M | 12.73% | 9,386 | - |
| 434 | MURA | Mural Oncology plc | 43.50M | 0.60% | 79,126 | - |
| 435 | ATNM | Actinium Pharmaceuticals, Inc. | 43.36M | 0.72% | 77,050 | 81.00K |
| 436 | PEPG | PepGen Inc. | 42.54M | 0.78% | 18,959 | - |
| 437 | IMRX | Immuneering Corporation | 42.35M | -0.84% | 129,071 | - |
| 438 | IRD | Opus Genetics, Inc. | 41.85M | -1.30% | 34,086 | 10.99M |
| 439 | HOWL | Werewolf Therapeutics, Inc. | 41.69M | - | 276,262 | 1.89M |
| 440 | STTK | Shattuck Labs, Inc. | 41.61M | -0.16% | 26,127 | 4.61M |
| 441 | FBRX | Forte Biosciences, Inc. | 41.60M | -5.11% | 2,754 | - |
| 442 | GRCE | Grace Therapeutics, Inc. | 41.43M | 2.37% | 160,065 | - |
| 443 | ESLA | Estrella Immunopharma, Inc. | 41.23M | 2.73% | 47,927 | - |
| 444 | AKTX | Akari Therapeutics, Plc | 40.86M | 3.28% | 10,832 | - |
| 445 | BRNS | Barinthus Biotherapeutics plc | 40.34M | 1.01% | 754 | 14.97M |
| 446 | MRSN | Mersana Therapeutics, Inc. | 39.45M | -0.09% | 671,322 | 40.50M |
| 447 | VRCA | Verrica Pharmaceuticals Inc. | 39.28M | -5.64% | 82,937 | 7.57M |
| 448 | ACRV | Acrivon Therapeutics, Inc. | 39.04M | -6.39% | 308,940 | - |
| 449 | ANTX | AN2 Therapeutics, Inc. | 38.23M | 10.43% | 201,969 | - |
| 450 | CELU | Celularity Inc. | 38.22M | 0.59% | 9,820 | 48.20M |
| 451 | PLUR | Pluri Inc. | 38.01M | 1.14% | 16,200 | 678.00K |
| 452 | RNXT | RenovoRx, Inc. | 37.66M | 0.04% | 26,324 | 43.00K |
| 453 | RNTX | Rein Therapeutics Inc. | 37.61M | -1.13% | 1,521 | - |
| 454 | BLUE | bluebird bio, Inc. | 37.10M | -1.30% | 26,248 | 83.81M |
| 455 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 36.57M | -0.79% | 134,740 | - |
| 456 | XLO | Xilio Therapeutics, Inc. | 35.21M | -1.90% | 205,980 | 6.34M |
| 457 | BOLD | Boundless Bio, Inc. | 34.23M | -4.66% | 42,404 | - |
| 458 | ADVB | Advanced Biomed Inc. | 34.19M | -17.28% | 353,696 | - |
| 459 | FGEN | FibroGen, Inc. | 33.55M | 14.01% | 604,824 | 29.62M |
| 460 | FBLG | FibroBiologics, Inc. | 33.48M | -1.78% | 47,209 | - |
| 461 | DYAI | Dyadic International, Inc. | 33.40M | -0.89% | - | 3.50M |
| 462 | RADX | Radiopharm Theranostics Limited | 33.31M | 4.47% | 10,445 | 204.61K |
| 463 | SPRO | Spero Therapeutics, Inc. | 32.98M | -3.28% | 94,557 | 47.98M |
| 464 | NRXP | NRx Pharmaceuticals, Inc. | 32.82M | 1.04% | 25,607 | - |
| 465 | MLEC | Moolec Science SA | 32.03M | 6.43% | 27,403 | 7.83M |
| 466 | LVTX | LAVA Therapeutics N.V. | 31.57M | 0.84% | 2,015 | 11.98M |
| 467 | ITRM | Iterum Therapeutics plc | 31.34M | -9.07% | 955,930 | - |
| 468 | KZR | Kezar Life Sciences, Inc. | 30.54M | 0.48% | 174,719 | - |
| 469 | ANVS | Annovis Bio, Inc. | 30.20M | 7.64% | 125,172 | - |
| 470 | CVKD | Cadrenal Therapeutics, Inc. | 29.81M | 1.15% | 8,668 | - |
| 471 | ALLK | Allakos Inc. | 29.57M | -0.15% | 125,034 | - |
| 472 | INKT | MiNK Therapeutics, Inc. | 29.27M | -7.52% | 4,117 | - |
| 473 | PYPD | PolyPid Ltd. | 29.17M | 5.62% | 7,259 | - |
| 474 | CASI | CASI Pharmaceuticals, Inc. | 28.51M | 2.23% | - | 28.54M |
| 475 | OKUR | OnKure Therapeutics, Inc. | 28.48M | -4.93% | 13,203 | - |
| 476 | CALC | CalciMedica, Inc. | 28.38M | 5.78% | 55,486 | - |
| 477 | COEP | Coeptis Therapeutics Holdings, Inc. | 27.96M | -0.12% | 16,792 | - |
| 478 | ALGS | Aligos Therapeutics, Inc. | 27.64M | -1.31% | 39,999 | 3.27M |
| 479 | BCAB | BioAtla, Inc. | 27.48M | -1.01% | 185,741 | 11.00M |
| 480 | GBIO | Generation Bio Co. | 26.40M | 5.26% | 53,932 | 19.89M |
| 481 | GDTC | CytoMed Therapeutics Limited | 26.31M | -0.44% | 548 | 368.84K |
| 482 | ALXO | ALX Oncology Holdings Inc. | 25.91M | -3.65% | 182,040 | - |
| 483 | ENLV | Enlivex Therapeutics Ltd. | 25.78M | -0.91% | 9,540 | - |
| 484 | OSRH | OSR Holdings, Inc. | 25.73M | 1.14% | 37,316 | - |
| 485 | DARE | Daré Bioscience, Inc. | 25.67M | - | 4,653 | 9.78K |
| 486 | NRSN | NeuroSense Therapeutics Ltd. | 23.99M | -3.00% | 126,867 | - |
| 487 | IGC | IGC Pharma, Inc. | 23.75M | 2.41% | 39,157 | 1.24M |
| 488 | KALA | KALA BIO, Inc. | 23.23M | 4.35% | 59,713 | - |
| 489 | PULM | Pulmatrix, Inc. | 22.80M | -2.60% | 3,644 | 7.81M |
| 490 | TPST | Tempest Therapeutics, Inc. | 22.74M | - | 20,576 | - |
| 491 | CMMB | Chemomab Therapeutics Ltd. | 22.63M | -1.64% | 52,786 | - |
| 492 | LSB | LakeShore Biopharma Co., Ltd | 22.52M | -1.67% | 6,963 | 79.42M |
| 493 | CGTX | Cognition Therapeutics, Inc. | 22.03M | -14.87% | 564,409 | - |
| 494 | PASG | Passage Bio, Inc. | 21.62M | 2.90% | - | - |
| 495 | CLGN | CollPlant Biotechnologies Ltd. | 21.53M | -2.59% | 5,410 | 515.00K |
| 496 | IPA | ImmunoPrecise Antibodies Ltd. | 21.35M | -2.08% | 171,185 | 16.58M |
| 497 | LGVN | Longeveron Inc. | 21.27M | -2.40% | 51,682 | 2.39M |
| 498 | CDIO | Cardio Diagnostics Holdings, Inc. | 21.21M | -4.84% | 312,685 | 34.89K |
| 499 | LEXX | Lexaria Bioscience Corp. | 20.65M | -1.85% | 33,366 | 525.92K |
| 500 | CVM | CEL-SCI Corporation | 20.53M | -0.85% | 217,104 | - |
| 501 | HOOK | HOOKIPA Pharma Inc. | 20.45M | 10.14% | 66,878 | 43.95M |
| 502 | SLGL | Sol-Gel Technologies Ltd. | 20.36M | -4.57% | 62,051 | 11.54M |
| 503 | ELEV | Elevation Oncology, Inc. | 20.24M | 0.97% | 288,036 | - |
| 504 | BIVI | BioVie Inc. | 20.20M | -5.60% | 646,774 | - |
| 505 | LSTA | Lisata Therapeutics, Inc. | 19.99M | 3.36% | 1,837 | 1.00M |
| 506 | OVID | Ovid Therapeutics Inc. | 19.94M | -2.20% | 185,986 | 566.00K |
| 507 | VYNE | VYNE Therapeutics Inc. | 19.80M | -1.11% | 243,119 | 501.00K |
| 508 | BCTX | BriaCell Therapeutics Corp. | 19.54M | -1.75% | 169,968 | - |
| 509 | QTTB | Q32 Bio Inc. | 19.27M | 2.60% | 28,645 | - |
| 510 | XFOR | X4 Pharmaceuticals, Inc. | 19.22M | 3.11% | 48,420 | 31.36M |
| 511 | ABVC | ABVC BioPharma, Inc. | 18.96M | 9.57% | 181,947 | 508.38K |
| 512 | NNVC | NanoViricides, Inc. | 18.93M | -4.05% | 35,395 | - |
| 513 | JUNS | Jupiter Neurosciences, Inc. | 18.90M | -6.52% | 20,996 | - |
| 514 | CRIS | Curis, Inc. | 18.50M | -0.46% | 36,708 | 11.20M |
| 515 | PMN | ProMIS Neurosciences, Inc. | 18.31M | -2.61% | 21,293 | - |
| 516 | ALLR | Allarity Therapeutics, Inc. | 17.78M | -2.34% | 403,147 | - |
| 517 | LPCN | Lipocine Inc. | 17.75M | -2.92% | 37,442 | 11.20M |
| 518 | SABS | SAB Biotherapeutics, Inc. | 16.35M | 5.39% | 35,380 | 1.32M |
| 519 | CANF | Can-Fite BioPharma Ltd. | 16.18M | 0.46% | 24,292 | 674.00K |
| 520 | EDSA | Edesa Biotech, Inc. | 15.87M | -2.59% | 2,686 | - |
| 521 | ASBP | Aspire Biopharma Holdings, Inc. | 15.58M | -9.46% | 93,670 | - |
| 522 | CLDI | Calidi Biotherapeutics, Inc. | 15.58M | -1.38% | 230,156 | - |
| 523 | GLYC | GlycoMimetics, Inc. | 15.48M | -0.46% | 53,821 | - |
| 524 | UBX | Unity Biotechnology, Inc. | 15.29M | -3.45% | 184,942 | - |
| 525 | NRXS | NeurAxis, Inc. | 15.01M | -5.02% | 32,615 | 2.69M |
| 526 | COCP | Cocrystal Pharma, Inc. | 15.01M | -2.32% | 8,135 | - |
| 527 | CING | Cingulate Inc. | 14.85M | -2.72% | 58,889 | - |
| 528 | PRTG | Portage Biotech Inc. | 14.20M | -1.82% | 30,742 | - |
| 529 | MEIP | MEI Pharma, Inc. | 14.11M | 1.23% | - | - |
| 530 | PHGE | BiomX Inc. | 14.10M | 2.84% | 11,361 | - |
| 531 | LPTX | Leap Therapeutics, Inc. | 14.09M | 1.88% | 66,528 | - |
| 532 | MBRX | Moleculin Biotech, Inc. | 13.89M | -2.72% | 55,888 | - |
| 533 | KAPA | Kairos Pharma, Ltd. | 13.69M | -4.28% | 150,270 | - |
| 534 | SYBX | Synlogic, Inc. | 13.66M | -0.17% | 21,969 | 8.00K |
| 535 | BOLT | Bolt Biotherapeutics, Inc. | 13.27M | -0.57% | 12,228 | 7.69M |
| 536 | BRTX | BioRestorative Therapies, Inc. | 13.22M | -1.06% | 2,528 | 401.00K |
| 537 | EQ | Equillium, Inc. | 13.22M | 0.65% | 28,340 | 41.10M |
| 538 | INAB | IN8bio, Inc. | 13.16M | -1.10% | 240,359 | - |
| 539 | GOVX | GeoVax Labs, Inc. | 12.73M | -1.14% | 80,819 | 5.59M |
| 540 | RLYB | Rallybio Corporation | 12.70M | 2.69% | 15,482 | 636.00K |
| 541 | BCDA | BioCardia, Inc. | 12.62M | 2.06% | 3,797 | 58.00K |
| 542 | BLRX | BioLineRx Ltd. | 12.37M | -1.83% | 6,070 | 28.94M |
| 543 | MRKR | Marker Therapeutics, Inc. | 12.21M | -7.32% | 44,766 | 6.59M |
| 544 | AFMD | Affimed N.V. | 12.15M | -6.15% | 48,391 | 6.29M |
| 545 | NXTC | NextCure, Inc. | 12.05M | -2.18% | 36,595 | - |
| 546 | HOTH | Hoth Therapeutics, Inc. | 11.85M | -2.49% | 40,855 | - |
| 547 | XTLB | XTL Biopharmaceuticals Ltd. | 11.78M | -5.56% | 16,078 | 451.00K |
| 548 | IMNN | Imunon, Inc. | 11.57M | -3.88% | 67,695 | - |
| 549 | CSCI | COSCIENS Biopharma Inc. | 11.30M | 0.80% | 1,480 | 9.59M |
| 550 | RLMD | Relmada Therapeutics, Inc. | 11.29M | -4.82% | 256,900 | - |
| 551 | ICU | SeaStar Medical Holding Corporation | 11.25M | 0.78% | 107,322 | 135.00K |
| 552 | NERV | Minerva Neurosciences, Inc. | 11.19M | -0.62% | 511 | - |
| 553 | ABP | Abpro Holdings, Inc. | 10.97M | -1.65% | 47,671 | 183.00K |
| 554 | CLRB | Cellectar Biosciences, Inc. | 10.89M | -1.83% | 167,860 | - |
| 555 | KPRX | Kiora Pharmaceuticals, Inc. | 10.17M | 2.73% | 7,171 | 16.02M |
| 556 | IMRN | Immuron Limited | 10.16M | 0.78% | 6,977 | 4.05M |
| 557 | SNSE | Sensei Biotherapeutics, Inc. | 10.08M | 0.65% | 11,082 | - |
| 558 | ERNA | Ernexa Therapeutics Inc. | 9.93M | -8.65% | - | 582.00K |
| 559 | PHIO | Phio Pharmaceuticals Corp. | 9.60M | 16.86% | 9,872,943 | - |
| 560 | APRE | Aprea Therapeutics, Inc. | 9.47M | -0.29% | 3,552 | 1.50M |
| 561 | ATHA | Athira Pharma, Inc. | 9.46M | -4.83% | 48,841 | - |
| 562 | DWTX | Dogwood Therapeutics, Inc. | 9.27M | 7.30% | 125,972 | - |
| 563 | PSTV | Plus Therapeutics, Inc. | 9.26M | 9.02% | 907,524 | 5.82M |
| 564 | EVAX | Evaxion Biotech A/S | 9.16M | -1.35% | 15,063 | 3.34M |
| 565 | NEUP | Neuphoria Therapeutics Inc. | 8.71M | -0.36% | 5,617 | 662.72K |
| 566 | RNAZ | TransCode Therapeutics, Inc. | 8.64M | 2.18% | 969,238 | - |
| 567 | INTS | Intensity Therapeutics, Inc. | 8.57M | 0.82% | 61,046 | - |
| 568 | BTAI | BioXcel Therapeutics, Inc. | 8.56M | -0.95% | 30,039 | 2.27M |
| 569 | SLXN | Silexion Therapeutics Corp | 8.41M | 2.33% | 337,358 | - |
| 570 | CARM | Carisma Therapeutics, Inc. | 8.33M | -10.39% | 639,287 | 19.63M |
| 571 | CYCN | Cyclerion Therapeutics, Inc. | 8.31M | 8.47% | 5,156 | 2.08M |
| 572 | IBIO | iBio, Inc. | 8.30M | -1.16% | 282,095 | 375.00K |
| 573 | BCLI | Brainstorm Cell Therapeutics Inc. | 7.99M | 1.26% | 36,394 | - |
| 574 | ACXP | Acurx Pharmaceuticals, Inc. | 7.72M | 2.67% | 14,624 | - |
| 575 | TSBX | Turnstone Biologics Corp. | 7.64M | -2.94% | 11,297 | - |
| 576 | EVGN | Evogene Ltd. | 7.60M | 0.88% | - | 8.51M |
| 577 | HCWB | HCW Biologics Inc. | 7.50M | -4.98% | 12,537 | 2.57M |
| 578 | PMCB | PharmaCyte Biotech, Inc. | 7.49M | -2.68% | 15,108 | - |
| 579 | JAGX | Jaguar Health, Inc. | 7.48M | 1.74% | 29,695 | 11.69M |
| 580 | TRAW | Traws Pharma, Inc. | 7.41M | -2.01% | 16,221 | 226.00K |
| 581 | LYRA | Lyra Therapeutics, Inc. | 7.07M | 4.61% | 24,493,916 | 1.19M |
| 582 | ADXN | Addex Therapeutics Ltd | 7.06M | 3.20% | 477 | 701.26K |
| 583 | CTXR | Citius Pharmaceuticals, Inc. | 6.87M | -3.88% | 57,072 | - |
| 584 | GNPX | Genprex, Inc. | 6.86M | -2.91% | 655,208 | - |
| 585 | PPBT | Purple Biotech Ltd | 6.71M | -1.79% | 45,488 | - |
| 586 | CHRO | Channel Therapeutics Corporation | 6.65M | -2.68% | 22,637 | - |
| 587 | APLM | Apollomics, Inc. | 6.41M | -4.60% | 331 | 198.00K |
| 588 | IBO | Impact BioMedical Inc. | 6.41M | -13.09% | 799,706 | - |
| 589 | MTVA | MetaVia Inc. | 6.31M | -1.50% | 299,435 | - |
| 590 | LIPO | Lipella Pharmaceuticals Inc. | 6.27M | - | - | 536.36K |
| 591 | INDP | Indaptus Therapeutics, Inc. | 6.20M | -5.73% | 64,131 | - |
| 592 | APM | Aptorum Group Limited | 6.11M | -0.57% | 23,389 | - |
| 593 | GTBP | GT Biopharma, Inc. | 6.04M | 3.93% | 2,739 | - |
| 594 | SNGX | Soligenix, Inc. | 6.01M | 0.80% | - | 119.37K |
| 595 | ATNF | 180 Life Sciences Corp. | 5.83M | -4.66% | 24,338 | - |
| 596 | AEON | AEON Biopharma, Inc. | 5.05M | -2.85% | 68,433 | - |
| 597 | DRMA | Dermata Therapeutics, Inc. | 4.99M | 1.28% | 149,336 | - |
| 598 | KLTO | Klotho Neurosciences, Inc. | 4.93M | -3.89% | 124,227 | - |
| 599 | CMND | Clearmind Medicine Inc. | 4.93M | -4.00% | 39,765 | - |
| 600 | CDT | Conduit Pharmaceuticals Inc. | 4.72M | -12.64% | 488,045 | - |
| 601 | XBIO | Xenetic Biosciences, Inc. | 4.67M | -2.26% | 817 | 2.50M |
| 602 | TCRT | Alaunos Therapeutics, Inc. | 4.64M | -1.38% | 20,820 | 10.00K |
| 603 | PLRZ | Polyrizon Ltd. | 4.62M | -10.51% | 1,752,339 | - |
| 604 | VRAX | Virax Biolabs Group Limited | 4.47M | 1.98% | - | 84.87K |
| 605 | ADIL | Adial Pharmaceuticals, Inc. | 4.40M | -3.42% | 166,726 | - |
| 606 | AZTR | Azitra, Inc. | 4.38M | 0.79% | 327,152 | 7.50K |
| 607 | HEPA | Hepion Pharmaceuticals, Inc. | 4.06M | 14.23% | 11,207,768 | - |
| 608 | SONN | Sonnet BioTherapeutics Holdings, Inc. | 3.99M | -1.52% | 8,379 | 1.00M |
| 609 | XRTX | XORTX Therapeutics Inc. | 3.93M | -1.91% | 1,247 | - |
| 610 | ALZN | Alzamend Neuro, Inc. | 3.92M | -6.53% | 860,775 | - |
| 611 | GLTO | Galecto, Inc. | 3.82M | -3.02% | 3,694 | - |
| 612 | KZIA | Kazia Therapeutics Limited | 3.80M | 5.57% | 8,824 | 1.66M |
| 613 | MBIO | Mustang Bio, Inc. | 3.73M | -0.44% | 75,863 | - |
| 614 | CERO | CERo Therapeutics Holdings, Inc. | 3.71M | -5.98% | 318,748 | - |
| 615 | OGEN | Oragenics, Inc. | 3.71M | -3.63% | 210,145 | - |
| 616 | QNRX | Quoin Pharmaceuticals, Ltd. | 3.70M | - | 14,353 | - |
| 617 | SILO | Silo Pharma, Inc. | 3.58M | -2.10% | 91,683 | 72.10K |
| 618 | TTNP | Titan Pharmaceuticals, Inc. | 3.54M | 1.04% | 105,744 | - |
| 619 | PALI | Palisade Bio, Inc. | 3.52M | -4.17% | - | - |
| 620 | NBY | NovaBay Pharmaceuticals, Inc. | 3.49M | 3.36% | - | 9.78M |
| 621 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 3.39M | -5.74% | 33,148 | 681.35K |
| 622 | SNPX | Synaptogenix, Inc. | 3.39M | 1.32% | 1,368 | - |
| 623 | BDRX | Biodexa Pharmaceuticals Plc | 3.33M | -2.26% | 26,900 | 104.90K |
| 624 | ARTL | Artelo Biosciences, Inc. | 3.31M | 1.00% | 7,912 | - |
| 625 | CNSP | CNS Pharmaceuticals, Inc. | 3.31M | 2.27% | 29,944 | - |
| 626 | SPRC | SciSparc Ltd. | 3.25M | -3.06% | 626,903 | 1.31M |
| 627 | THAR | Tharimmune, Inc. | 3.25M | -6.67% | 54,521 | - |
| 628 | VIVS | VivoSim Labs, Inc. | 3.22M | -1.56% | 1,029,956 | 122.00K |
| 629 | WINT | Windtree Therapeutics, Inc. | 3.21M | 0.26% | - | - |
| 630 | LIXT | Lixte Biotechnology Holdings, Inc. | 3.17M | -6.35% | 9,240 | - |
| 631 | MTNB | Matinas BioPharma Holdings, Inc. | 3.15M | -2.52% | 177 | - |
| 632 | GLMD | Galmed Pharmaceuticals Ltd. | 3.12M | -5.48% | 712,814 | - |
| 633 | ENVB | Enveric Biosciences, Inc. | 3.02M | 0.83% | 15,867 | - |
| 634 | EYEN | Eyenovia, Inc. | 2.97M | 1.94% | 8,608 | 57.34K |
| 635 | ENSC | Ensysce Biosciences, Inc. | 2.94M | -3.46% | 88,826 | 5.21M |
| 636 | KTTA | Pasithea Therapeutics Corp. | 2.83M | -31.25% | 3,201,953 | - |
| 637 | REVB | Revelation Biosciences, Inc. | 2.74M | 4.48% | 2,149 | - |
| 638 | SCNI | Scinai Immunotherapeutics Ltd. | 2.62M | -3.26% | 7,769 | 452.00K |
| 639 | NLSP | NLS Pharmaceutics AG | 2.60M | -7.51% | 23,526 | - |
| 640 | QLGN | Qualigen Therapeutics, Inc. | 2.58M | 1.45% | 2,770 | - |
| 641 | PBM | Psyence Biomedical Ltd. | 2.50M | -1.01% | 49,879 | - |
| 642 | PTN | Palatin Technologies, Inc. | 2.49M | -43.76% | 14,569,163 | 350.00K |
| 643 | ZVSA | ZyVersa Therapeutics, Inc. | 2.28M | 14.30% | 63,434,021 | - |
| 644 | NCNA | NuCana plc | 2.24M | -8.44% | 7,621,906 | - |
| 645 | ADTX | Aditxt, Inc. | 2.23M | -7.69% | 86,490 | 133.99K |
| 646 | TOVX | Theriva Biologics, Inc. | 2.20M | -41.91% | 44,910,873 | - |
| 647 | TNFA | TNF Pharmaceuticals, Inc. | 1.91M | -5.19% | 568,172 | - |
| 648 | ENTO | Entero Therapeutics, Inc. | 1.74M | 2.70% | - | - |
| 649 | PTIX | Protagenic Therapeutics, Inc. | 1.66M | -5.79% | 87,602 | - |
| 650 | ELAB | PMGC Holdings Inc. | 1.63M | -4.96% | 74,811 | 2.45M |
| 651 | PCSA | Processa Pharmaceuticals, Inc. | 1.32M | -4.07% | 719,990 | - |
| 652 | SLRX | Salarius Pharmaceuticals, Inc. | 1.27M | -0.25% | - | - |
| 653 | APVO | Aptevo Therapeutics Inc. | 1.27M | -3.66% | 326,765 | - |
| 654 | GRI | GRI Bio, Inc. | 998.18K | -0.52% | 102,511 | - |
| 655 | ONCO | Onconetix, Inc. | 617.96K | 7.35% | 5,593,461 | 1.87M |